CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹149 Cr | ₹129 Cr | ₹102 Cr | ₹100 Cr | ₹116 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹149 Cr |
Mar2024 | ₹129 Cr |
Mar2023 | ₹102 Cr |
Mar2022 | ₹100 Cr |
Mar2021 | ₹116 Cr |
How is Long Term Provisions of CIPLA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹149 Cr | 15.03 | |
Mar2024 | ₹129 Cr | 26.53 | |
Mar2023 | ₹102 Cr | 1.94 | |
Mar2022 | ₹100 Cr | -13.73 | |
Mar2021 | ₹116 Cr | - |
Compare Long Term Provisions of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹129,336.9 Cr | 3.4% | 7.7% | 0.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,498.0 Cr | 1.9% | -2.1% | -6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,838.0 Cr | 2.7% | -5.6% | 25.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,235.0 Cr | 0.6% | 4.4% | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,211.0 Cr | 3.2% | 1.6% | -8.4% | Stock Analytics | |
MANKIND PHARMA | ₹105,553.0 Cr | 2.7% | -1.2% | 12.3% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 3.4% |
7.7% |
0.4% |
SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses